Although it has rebounded significantly in recent days, A-Shares have still fallen a lot this year. However, in this market, there are still many big bull stocks, such as China Meheco Group Co.Ltd(600056) , which has risen by 10 limits in the last 13 trading days, and Zhejiang Construction Investment Group Co.Ltd(002761) , which has soared by 406% this year.
The latest March 18, the two stocks are trading limit. On the same day, heavy news came out, China Meheco Group Co.Ltd(600056) said that the first batch of Pfizer covid-19 oral drugs had arrived, Zhejiang Construction Investment Group Co.Ltd(002761) was subject to key supervision.
soared by 200% and released heavy news:
the first batch of 20000 boxes of imported anti covid-19 drugs have arrived
China Meheco Group Co.Ltd(600056) share price closed the trading limit again after the huge intraday earthquake on March 18, with a turnover of 6.7 billion yuan and a turnover rate of nearly 20%. The share price closed at 33.26 yuan and the market value reached 35.5 billion yuan. It has been trading for three consecutive days, with 10 trading limits in the last 13 trading days. From the trading limit on March 2, the company’s share price started from 11.1 yuan, and has increased by 200% so far.
After hours, China Meheco Group Co.Ltd(600056) said that on March 17, the company completed the import customs clearance procedures of the first batch of the products.
Behind the huge fluctuations in China Meheco Group Co.Ltd(600056) ‘s share price, the company will operate commercial COVID-19 in Chinese mainland in 2022s. 6 Shaanxi International Trust Co.Ltd(000563) 9 announcement, the company signed an agreement with Pfizer Inc in March 9th, will be responsible for the commercial operation of Pfizer Inc COVID-19 virus treatment PAXLOVID in Chinese mainland market in the agreement period (2022). Before that, there were rumors about the company’s cooperation with Pfizer in the market.
On March 18, China Meheco Group Co.Ltd(600056) issued an announcement of abnormal trading fluctuations and said that on March 17, the company completed the import customs clearance procedures of the first batch of the product and is fully cooperating with the state in the fight against covid-19 epidemic.
According to Wen Wei Po, at 22:30 on March 17, 21200 boxes of imported anti-covid-19 virus drug “paxlovid tablets” (paxlovid) were inspected and released by the customs of Shanghai Shanghai Waigaoqiao Free Trade Zone Group Co.Ltd(600648) Free Trade Zone, all import customs clearance procedures were completed and rushed to the front line of national anti epidemic. This is the first batch of imported drugs in China after paxlovid was included in the latest version of covid-19 pneumonia diagnosis and treatment program.
share price soared, and the company also suggested risks
Although the progress of imported covid-19 drugs is good, China Meheco Group Co.Ltd(600056) also reminds investors to pay attention to investment risks.
The company said that as of the closing date of March 18, 2022, after inquiry, the median price earnings ratio (TTM) of the pharmaceutical circulation industry was 15.32, and the company’s price earnings ratio (TTM) was 39.13, which was significantly higher than the price earnings ratio of the same industry. The recent rise of the company’s share price may have exceeded the impact of relevant matters on the company’s performance, and there may be irrational investment. Please pay attention to investment risks, make rational decisions and invest prudently.
On February 11, 2022, the State Drug Administration conducted emergency review and approval in accordance with the special drug approval procedures, and approved the import registration of Pfizer covid-19 virus treatment drug paxlovid with conditions.
PAXLOVID is an oral small molecule COVID-19 virus therapy for the treatment of mild to moderate New Coronavirus pneumonia (COVID-19) in adults with severe risk factors, such as elderly, chronic kidney disease, diabetes, cardiovascular disease, and chronic lung disease.
The China Meheco Group Co.Ltd(600056) announcement pointed out that the above products were prescription drugs. In March 15th, the national health and Health Committee issued the New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth), which was included in the ninth edition of the diagnosis and treatment plan, but has not yet entered the national health insurance. If it is included in the national medical insurance, it may have an impact on the sales price. The final use and sales of the product are affected by factors such as epidemic prevention and control, and there is great uncertainty. It is expected that the relevant business scale accounts for a small proportion of the company’s overall business volume, which has no significant impact on the company’s recent operating performance.
this year’s largest Bull Stock
soared by 406% under key monitoring
Not only did China Meheco Group Co.Ltd(600056) share price fluctuate abnormally, but also Zhejiang Construction Investment Group Co.Ltd(002761) 318 raised the limit again. Since this year, the share price has soared by 406%, which is the largest Bull Stock in this year Zhejiang Construction Investment Group Co.Ltd(002761) recently, the trading limit was 5 in 6 trading days, and 10 in 11 consecutive trading days before that.
After the continuous sharp rise, the Shenzhen Stock Exchange announced that from March 14 to March 18, the exchange had taken self-discipline and supervision measures for 67 abnormal securities transactions, involving intraday lifting and suppression, false declaration and other abnormal transactions; Focus on monitoring the ” Zhejiang Construction Investment Group Co.Ltd(002761) ” with abnormal recent increase; A total of 9 major events of listed companies were verified.
As a capital construction stock, Zhejiang Construction Investment Group Co.Ltd(002761) such a sharp rise makes people feel “confused”. The company also said that the main construction industry has not changed, and there are no matters that should be disclosed but not disclosed.
At present, the company’s business composition has not changed significantly. The company’s main business is construction and industrial manufacturing, engineering services, infrastructure investment and operation matched with the main construction industry chain. The company has no major information that should be disclosed but not disclosed, and the company’s fundamentals have not changed significantly.
The company also suggests that investors should fully understand the stock market risks and the risk factors disclosed in the company’s periodic reports, pay attention to the transaction risks in the secondary market, make prudent decisions, invest rationally, improve risk awareness and avoid blindly following the trend.
According to market analysis, Zhejiang Construction Investment Group Co.Ltd(002761) is classified as the concept of Zhejiang common prosperity demonstration area and the concept stock of Rural Revitalization.
The national development and Reform Commission held a press conference on February 17 to introduce the promotion of supporting the high-quality development and construction of common prosperity demonstration zone in Zhejiang Province, which made Zhejiang “brush the screen” instantly. Among them, two highlights are of the greatest concern: in 2025, the annual disposable income of 80% of households will reach 1 Shenzhen Fountain Corporation(000005) 00000 yuan; If college students fail to start a business in Zhejiang, the government will compensate for the loan of less than 100000 yuan.
It is reported that the national development and Reform Commission will also promote the formulation and promulgation of the action platform for promoting common prosperity, and take the lead in studying and formulating the implementation plan for expanding middle-income groups and studying and constructing the monitoring and evaluation system for promoting common prosperity. The goal is all common prosperity.
institutional trading China Meheco Group Co.Ltd(600056)
hot money speculation Zhejiang Construction Investment Group Co.Ltd(002761)
From the trading seats of the Dragon Tiger list, China Meheco Group Co.Ltd(600056) , with the agent of imported covid-19, bought 280 million yuan of seats of the two institutions on the day when the one-stop trading board was opened on March 15. However, after a large increase in institutional seats, they rose by three limits. Among the seats on March 18, one institutional seat sold more than 200 million.
Zhejiang Construction Investment Group Co.Ltd(002761) recent trading seats are basically hot money seats in the business department of securities companies.
